Insiders / Orbimed Advisors LLC / Activity
Activity — Orbimed Advisors LLC
37 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | Sell | ELVN Enliven Therapeutics, Inc. Common Stock | $35.72M | -787K -10.65% | 6,601,878 9.01% of shares | high |
| Jun 15, 2026 | Sell | ELVN Enliven Therapeutics, Inc. Common Stock | $12.26M | -272K -3.55% | 7,388,902 10.08% of shares | high |
| Apr 15, 2026 | Sell | SION Sionna Therapeutics, Inc. Common Stock | $10.53M | -236K -6.77% | 3,247,025 7.18% of shares | medium |
| Apr 16, 2026 | Sell | SION Sionna Therapeutics, Inc. Common Stock | $10.29M | -227K -6.99% | 3,020,119 6.68% of shares | medium |
| May 28, 2026 | Buy | QTTB Q32 Bio Inc. Common Stock | $10.00M | +1.3M +55.48% | 3,502,987 11.77% of shares | high |
| May 11, 2026 | Sell | SION Sionna Therapeutics, Inc. Common Stock | $8.53M | -185K -6.46% | 2,671,822 5.91% of shares | medium |
| Apr 21, 2026 | Buy | PRLD Prelude Therapeutics Incorporated Common Stock | $7.50M | +1.7M +16.69% | 11,808,945 14.80% of shares | high |
| May 28, 2026 | Buy | QTTB Q32 Bio Inc. Common Stock | $5.00M | +625K | 625,000 2.10% of shares | high |
| Apr 21, 2026 | Buy | PRLD Prelude Therapeutics Incorporated Common Stock | $5.00M | +1.1M | 1,126,126 1.41% of shares | high |
| May 8, 2026 | Sell | SION Sionna Therapeutics, Inc. Common Stock | $2.66M | -60K -2.05% | 2,856,461 6.32% of shares | medium |
| Apr 17, 2026 | Sell | SION Sionna Therapeutics, Inc. Common Stock | $2.34M | -52K -1.73% | 2,967,722 6.56% of shares | medium |
| May 7, 2026 | Sell | SION Sionna Therapeutics, Inc. Common Stock | $2.17M | -49K -1.64% | 2,916,228 6.45% of shares | medium |
| Apr 14, 2026 | Sell | SION Sionna Therapeutics, Inc. Common Stock | $2.13M | -48K -1.35% | 3,482,888 7.70% of shares | medium |
| Jun 22, 2026 | Sell | ELVN Enliven Therapeutics, Inc. Common Stock | $2.10M | -47K -0.71% | 6,555,102 8.95% of shares | medium |
| Feb 3, 2026 | Sell | SION Sionna Therapeutics, Inc. Common Stock | $1.30M | -29K -0.82% | 3,530,702 7.81% of shares | medium |
| Jun 22, 2026 | Sell | ELVN Enliven Therapeutics, Inc. Common Stock | $1.13M | -25K -10.11% | 220,882 0.30% of shares | medium |
| Apr 16, 2026 | Buy | TRAW Traws Pharma, Inc. Common Stock | $998.2K | +598K +98.71% | 1,203,250 7.94% of shares | high |
| Jun 15, 2026 | Sell | ELVN Enliven Therapeutics, Inc. Common Stock | $409.1K | -9K -3.57% | 245,728 0.34% of shares | medium |
| Apr 8, 2026 | Sell | ACET Adicet Bio, Inc. Common Stock | $263.5K | -40K -100.00% | 0 0.00% of shares | medium |
| Apr 8, 2026 | Sell | ACET Adicet Bio, Inc. Common Stock | $204.6K | -33K -100.00% | 0 0.00% of shares | medium |
| Apr 7, 2026 | Sell | ACET Adicet Bio, Inc. Common Stock | $191.5K | -29K -45.64% | 34,923 0.37% of shares | medium |
| Apr 18, 2026 | Sell | SION Sionna Therapeutics, Inc. Common Stock | $131.2K | -3K -0.10% | 2,964,774 6.56% of shares | medium |
| Feb 2, 2026 | Sell | SION Sionna Therapeutics, Inc. Common Stock | $84.2K | -2K -0.05% | 3,559,765 7.87% of shares | low |
| Jun 22, 2026 | Sell | ELVN Enliven Therapeutics, Inc. Common Stock | $66.5K | -1K -0.67% | 219,405 0.30% of shares | low |
| Apr 7, 2026 | Sell | ACET Adicet Bio, Inc. Common Stock | $15.3K | -2K -6.87% | 32,523 0.35% of shares | low |
| May 27, 2026 | Sell | SION Sionna Therapeutics, Inc. Common Stock | $4.5K | -101 -0.00% | 2,671,721 5.91% of shares | low |
| Jun 11, 2026 | Buy | STTK Shattuck Labs, Inc. Pre-Funded Warrants (right to buy) | — | +208K +4.09% | 5,303,908 5.28% of shares | low |
| Jun 11, 2026 | Buy | STTK Shattuck Labs, Inc. Pre-Funded Warrants (right to buy) | — | +1.0M +4.09% | 26,519,541 26.42% of shares | low |
| Jun 8, 2026 | Other | STTK Shattuck Labs, Inc. Common Warrants (right to buy) | — | -3.1M -100.00% | 0 0.00% of shares | low |
| Jun 8, 2026 | Other | STTK Shattuck Labs, Inc. Common Warrants (right to buy) | — | -15.4M -100.00% | 0 0.00% of shares | low |
| Jun 8, 2026 | Other | STTK Shattuck Labs, Inc. Pre-Funded Warrants (right to buy) | — | +3.1M +151.97% | 5,095,575 5.08% of shares | low |
| Jun 8, 2026 | Other | STTK Shattuck Labs, Inc. Pre-Funded Warrants (right to buy) | — | +15.4M +151.97% | 25,477,874 25.39% of shares | low |
| Apr 16, 2026 | Buy | TRAW Traws Pharma, Inc. Series C Warrants (right to buy) | — | +1.8M | 1,793,187 11.84% of shares | low |
| Apr 16, 2026 | Buy | TRAW Traws Pharma, Inc. Series B Warrants (right to buy) | — | +598K | 597,729 3.95% of shares | low |
| Apr 16, 2026 | Buy | TRAW Traws Pharma, Inc. Series A Warrants (right to buy) | — | +598K | 597,729 3.95% of shares | low |
| Apr 14, 2026 | Buy | IMA ImageneBio, Inc. Pre-Funded Warrants (right to buy) | — | +385K | 384,689 3.39% of shares | low |
| Apr 14, 2026 | Buy | IMA ImageneBio, Inc. Pre-Funded Warrants (right to buy) | — | +337K | 336,603 2.97% of shares | low |